As of 2026-03-17, the Relative Valuation of Pfizer Inc (PFE) is 25.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.61 USD, the upside of Pfizer Inc based on Relative Valuation is -4.0%.
The range of the Relative Valuation is 21.91 - 32.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 23.7x | 19.1x |
| Forward P/E multiples | 16.5x - 20.3x | 18.8x |
| Fair Price | 21.91 - 32.39 | 25.53 |
| Upside | -17.6% - 21.7% | -4.0% |
| Date | P/E |
| 2026-03-16 | 19.47 |
| 2026-03-13 | 19.45 |
| 2026-03-12 | 19.65 |
| 2026-03-11 | 19.98 |
| 2026-03-10 | 19.87 |
| 2026-03-09 | 19.62 |
| 2026-03-06 | 19.79 |
| 2026-03-05 | 19.47 |
| 2026-03-04 | 19.48 |
| 2026-03-03 | 19.45 |
| 2026-03-02 | 19.95 |
| 2026-02-27 | 20.23 |
| 2026-02-26 | 19.83 |
| 2026-02-25 | 19.82 |
| 2026-02-24 | 19.86 |
| 2026-02-23 | 19.80 |
| 2026-02-20 | 19.50 |
| 2026-02-19 | 19.65 |
| 2026-02-18 | 20.03 |
| 2026-02-17 | 20.03 |
| 2026-02-13 | 20.18 |
| 2026-02-12 | 20.10 |
| 2026-02-11 | 20.29 |
| 2026-02-10 | 20.20 |
| 2026-02-09 | 19.79 |
| 2026-02-06 | 19.92 |
| 2026-02-05 | 19.38 |
| 2026-02-04 | 19.60 |
| 2026-02-03 | 18.86 |
| 2026-02-02 | 19.51 |
| 2026-01-30 | 19.35 |
| 2026-01-29 | 19.10 |
| 2026-01-28 | 18.92 |
| 2026-01-27 | 19.39 |
| 2026-01-26 | 18.94 |
| 2026-01-23 | 18.77 |
| 2026-01-22 | 19.10 |
| 2026-01-21 | 18.94 |
| 2026-01-20 | 18.67 |
| 2026-01-16 | 18.77 |
| 2026-01-15 | 18.94 |
| 2026-01-14 | 18.72 |
| 2026-01-13 | 18.40 |
| 2026-01-12 | 18.49 |
| 2026-01-09 | 18.64 |
| 2026-01-08 | 18.51 |
| 2026-01-07 | 18.50 |
| 2026-01-06 | 18.61 |
| 2026-01-05 | 18.42 |
| 2026-01-02 | 18.42 |